Elevance Health (ELV) closed at $429.65 on November 10, 2026, up 2.7% from the previous close, on volume of 841,903 shares (30-day average 1,340,616).
Data as of November 10, 2026.
10-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 5, 2026 | Diagonal Put Spread | 18-Dec-26 : 19-Mar-27340 : 270 P | 460 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 9, 2026. See the 10 largest for 30, 60 and 90 days
Elevance Health Officers to Reaffirm 2026 Earnings Guidance
TipRanks (Tue, 10-Nov 5:28 PM ET)
Elevance Health Taps Jeff Park to Lead Carelon as President Starting December 1, 2026
Market Chameleon (Wed, 21-Oct 5:00 AM ET)
Elevance Health Names Jeff Park President of Carelon
Business Wire (Wed, 21-Oct 7:30 AM ET)
Elevance Health Reports Third Quarter 2026 Results; Raises Full-Year Guidance
Business Wire (Wed, 21-Oct 6:00 AM ET)
The Future of Healthcare: AI-Powered, Coordinated and Proactive Care
Globe Newswire (Mon, 19-Oct 8:30 AM ET)
Did Elevance Health, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
PRNewswire (Thu, 8-Oct 2:54 PM ET)
Business Wire (Mon, 5-Oct 8:00 AM ET)
Business Wire (Thu, 1-Oct 7:00 AM ET)
Market Chameleon (Wed, 15-Jul 3:06 AM ET)
Market Chameleon (Wed, 28-Jan 2:14 AM ET)
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
Elevance Health trades on the NYSE stock market under the symbol ELV.
As of November 10, 2026, ELV stock price climbed to $429.65 with 841,903 million shares trading.
ELV has a beta of 0.77, meaning it tends to be less sensitive to market movements. ELV has a correlation of 0.10 to the broad based SPY ETF.
ELV has a market cap of $93.18 billion. This is considered a Large Cap stock.
Last quarter Elevance Health reported $50 billion in Revenue and $6.99 earnings per share. This beat revenue expectation by $1 billion and exceeded earnings estimates by $2.30.
In the last 3 years, ELV traded as high as $567.26 and as low as $273.71.
The top ETF exchange traded funds that ELV belongs to (by Net Assets): VTI, VOO, IVV, SPY, VTV.
ELV has outperformed the market in the last year with a price return of +37.4% while the SPY ETF gained +12.9%. ELV has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +9.4% and -0.4%, respectively, while the SPY returned -2.8% and -2.0%, respectively.
ELV support price is $409.86 and resistance is $426.64 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ELV shares will trade within this expected range on the day.
